09.02.2005 17:02:00

Klee Group Joins MDL Isentris Alliance; Alliance Program Increases Int

Klee Group Joins MDL Isentris Alliance; Alliance Program Increases Integrated Research Solutions for Life Scientists


    Business Editors/Health/Medical Writers
    BIOWIRE2K

    SAN LEANDRO, Calif. and PARIS--(BUSINESS WIRE)--Feb. 9, 2005--Klee Group, a technology consulting and engineering firm, has joined the MDL(R) Isentris(R) Alliance, an Elsevier MDL program designed to maximize opportunities for life sciences researchers using the new MDL Isentris information management and integration platform. Isentris Alliance is a community of companies joining forces to provide biopharmaceutical companies with research solutions that improve the value of software and services from different vendors.
    "The Isentris Alliance, by establishing relationships among industry leaders in software, content, hardware and other services, will offer customers opportunities to leverage existing specialized software and services in comprehensive discovery solutions that improve the productivity of discovery research," said Jean Colombel, senior vice president of Elsevier MDL sales and services. "We're excited to welcome Klee Group and its global force of technology experts to the Isentris Alliance."
    With its partnership in the Isentris Alliance, the Klee Group extends its expertise in information systems and R&D issues for the life sciences. "Our purpose is to materialize quickly and reliably the benefits of new technology for our customers," says Klee Group CEO Thibaud L. Viala. "Our partnership in the new Isentris Alliance will support our commitment to create innovative, high-value solutions for clients."
    The innovative MDL Isentris informatics platform provides life sciences organizations with an open environment for integrating complex information and applications. Isentris is the only fully supported, three-tier architecture specifically designed for research that facilitates the integration of an organization's business processes, data and workflow applications. For researchers, the Isentris Alliance brings value to the desktop by facilitating workflow between applications and services from an array of specialized vendors, ultimately supporting the goal of providing a comprehensive, self-service research environment for scientists.
    The Isentris Alliance will take advantage of partner members' core competencies and combine these strengths using the common Isentris platform. The Alliance program helps vendors to work together, share knowledge and explore new opportunities while offering an immediate distribution channel and opportunities for marketing partnerships and development.
    The Isentris Alliance formally begins in July 2005. Contact an Elsevier MDL representative for more information.

    About Elsevier MDL

    Elsevier MDL provides informatics, database, workflow and decision support solutions that accelerate the discovery and development of successful new drugs by improving the speed and quality of scientists' decision making. Commercial, academic and government life sciences researchers around the world depend on Elsevier MDL for innovative and reliable discovery informatics software solutions and services augmented by 400 Elsevier chemistry and life sciences journals and related products. For more information, visit www.mdl.com.
    Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, the company publishes more than 1,800 journals and 2,200 new books per year, in addition to offering a suite of innovative electronic products and online reference works. For more information visit www.elsevier.com.
    Elsevier is part of Reed Elsevier Group plc, a world-leading publisher and information provider. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange). For more information visit www.reedelsevier.com.

    About Klee Group

    Klee Group (www.KleeGroup.com) is a technology consulting and engineering firm, headquartered in Paris, France. With more than 200 consultants and customers in over 30 countries, Klee Group specializes in strategic e-Business projects and Internet technologies. Klee Group provides its life sciences customers with the combination of understanding R&D issues and expertise in information systems that is needed to deliver efficient solutions on budget and on time. In its approach, Klee Group balances a taste for innovation with a strong dose of methodology and professionalism.

    MDL and Isentris are registered trademarks of MDL Information Systems, Inc. in the United States. All rights reserved.

--30--NL/sf*

CONTACT: Elsevier MDL Dr. Phil McHale, 510-357-2222 ext. 3541 email: p.mchale@mdl.com or Klee Group M. Thibaud L. Viala, 33.(0)1.46.29.25.25 email: contact@kleegroup.com

KEYWORD: CALIFORNIA UNITED KINGDOM FRANCE INTERNATIONAL EUROPE Biomedical INDUSTRY KEYWORD: MEDICAL PHARMACEUTICAL BIOTECHNOLOGY SOFTWARE PUBLISHING PRODUCT MARKETING AGREEMENTS SOURCE: Elsevier MDL

Copyright Business Wire 2005

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu RELX NV (ex Reed Elsevier)mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu RELX NV (ex Reed Elsevier)mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

AEX 895,83 0,77%
EURO STOXX 515,52 0,41%